Wed01272021

Last updateWed, 13 Jan 2021 10am

Back You are here: Inicio Biology & biomedicine

Conversation with researcher Anna Planas about her Covid-19 project

The CSIC launches a genetic study to identify the individual risk of developing severe forms of Covid-19. We converse about the project with Anna Planas, a CSIC researcher at the Institute of Biomedical Research of Barcelona (IIBB-CSIC).

Read more ...

Silicon technologies against Covid-19

In the Clean Room of the Barcelona Microelectronics Institute (IMB-CNM-CSIC) scientists are developing devices for COVID-1 diagnostic sensors. This work is part of two projects: Convat , led by ICN2, and POC4CoV, co-led by the Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) and the IMB-CNM, CSIC.

Read more ...

A project aimed at developing a tool for the diagnosis and monitoring of cystinosis

The Institute for Advanced Chemistry of Catalonia (IQAC) of the CSIC leads a project aimed at developing a tool for the diagnosis and monitoring of cystinosis, a rare disease. The tool could reduce the time that patients, especially children, have to spend at the hospital. The project has received a grant from the AGAUR agency and from the European ERDF funds.

Read more ...

Gut bacteria to treat depression and anxiety

CSIC researchers have patented a gut bacteria called Christensenella minuta that has therapeutic applications to treat mood disorders, such as depression and anxiety. This technology has been developed by a team at the Institute of Agrochemistry and Food Technology (IATA-CSIC), and has has already been licensed to LNC Therapeutics, a French biotechnology company specialized in research and development of drugs in the area of ​​the intestinal microbiome.

Read more ...

Dressings made of biologically active nanocellulose for treating corneal wounds

Scientists at the ICMAB-CSIC have published the firsts results of this innovative ophthalmological treatment in the Biomaterials Science magazine. Bacterial nanocellulose is more affordable and easy to preserve than current treatments, and it will be impregnated with growth factors to accelerate corneal regeneration. The research is developed in close collaboration with the Barraquer Ophthalmology Centre in Barcelona, which supports this project from a clinical perspective.

Read more ...